Debela Ejeta | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Debela Ejeta
Ambo University

Debela Ejeta
Affiliation Ambo University
Country Ethiopia
Scopus ID 57823056300
Documents 3
Citations 638
h-index 2
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2289-0397

Debela Ejeta is a researcher affiliated with Ambo University, Ethiopia, whose documented scholarly profile is associated with cardiology. The supplied bibliometric record identifies three documents, 638 citations, and an h-index of 2. Bibliometric measures are useful for describing research visibility but should be considered together with publication quality, originality, methodological rigor, relevance, and broader contribution when evaluating academic recognition. [1]

Abstract

Debela Ejeta is an academic researcher affiliated with Ambo University in Ethiopia and associated with the subject area of cardiology. The supplied scholarly record reports three documents, 638 citations, and an h-index of 2, providing measurable evidence of indexed research activity and citation visibility. This article presents a neutral academic profile in relation to the Best Researcher Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. The assessment considers documented publication activity, significance, reproducibility, and contribution to cardiovascular research and scientific knowledge. [1]

Keywords

Debela Ejeta; Ambo University; Cardiology; Cardiovascular Medicine; Clinical Research; Research Impact; Bibliometrics; Scholarly Communication; Best Researcher Award; Cardiovascular Research.

Introduction

Cardiology research combines clinical investigation, biomedical science, epidemiology, and quantitative approaches to improve understanding of cardiovascular conditions. Researchers contribute through evidence generation, publication, interpretation, and dissemination of findings. Debela Ejeta is presented within this academic context as an Ambo University researcher associated with cardiology. Established research-metrics guidance recommends that quantitative indicators be interpreted carefully and alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Research Profile

Debela Ejeta’s documented academic profile identifies Ambo University as the institutional affiliation and Ethiopia as the country of association. The supplied indexed record contains three documents, with 638 citations and an h-index of 2. These metrics indicate measurable scholarly visibility within the available record, although they do not independently establish the quality, authorship contribution, originality, or practical significance of individual studies. [1]

Research Contributions

The documented research profile of Debela Ejeta is situated within cardiology, a field where scholarly investigation can contribute to improved understanding of cardiovascular health and disease. The available information establishes subject relevance and measurable citation activity but does not provide sufficient publication-level evidence to attribute specific discoveries, clinical innovations, or methodological advances. Detailed contribution assessment should therefore examine individual studies, and relevance to cardiovascular medicine.

Publications

The supplied Scopus information records three documents associated with Debela Ejeta’s indexed scholarly profile. Because publication titles, journal names, publication dates, author lists, and DOI identifiers were not supplied in the input data, individual publications are not reproduced here to avoid unsupported attribution. A complete publication review should verify each indexed record against the original article and bibliographic source, including authorship, journal information, DOI metadata, citation count, and substantive relationship to cardiology. [1]

Research Impact

The reported profile contains 638 citations across three indexed documents and an h-index of 2. Citation counts can indicate that published research has been referenced by subsequent scholarly work, while the h-index combines publication and citation dimensions into a single indicator. Such measures vary according to discipline, publication type, research community, and other contextual factors. [2]

Award Suitability

Debela Ejeta demonstrates documented characteristics relevant to consideration for the Best Researcher Award, including an academic affiliation with Ambo University, a stated research focus in cardiology, indexed scholarly documents, and measurable citation activity. The reported citation record provides evidence of scholarly visibility. Final award suitability should, however, be established through independent review of the underlying publications, originality, methodological rigor, research relevance, ethical standards, authorship contribution, and broader academic or clinical significance. These qualitative dimensions provide necessary context for interpreting bibliometric evidence.

Conclusion

Debela Ejeta is an Ambo University researcher associated with cardiology and documented through the supplied scholarly profile as having three documents, 638 citations, and an h-index of 2. These indicators provide measurable evidence of indexed research activity and citation visibility. In the context of the Best Researcher Award, the available information supports consideration for further academic evaluation. A final recognition decision should incorporate verified publication-level evidence and qualitative assessment of originality, rigor, relevance, contribution, and potential significance within cardiovascular research. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Debela Ejeta, Author ID 57823056300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57823056300
  2. Journal article (2026. ) Prevalence of atrial fibrillation and associated factors among adult cardiac patients at Ambo University Referral Hospital, West Shewa, Ethiopia, 2024/2025.
    https://doi.org/10.1016/j.ahjo.2026.100832
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Sandra Celina Fernandes Fonseca | Cardiology | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Sandra Celina Fernandes Fonseca
University of Trás-os-Montes and Alto Douro
Sandra Celina Fernandes Fonseca
Affiliation University of Trás-os-Montes and Alto Douro
Country Portugal
Scopus ID 57191525441
Documents 23
Citations 85
h-index 5
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9468-7269

The Innovative Research Award recognizes sustained scholarly contributions that advance evidence-based understanding in cardiovascular and health sciences. Sandra Celina Fernandes Fonseca, affiliated with the University of Trás-os-Montes and Alto Douro, has developed an interdisciplinary research portfolio examining exercise physiology, cardiovascular responses, athlete well-being, and health promotion across diverse populations. Her publication record demonstrates engagement with clinically relevant topics at the intersection of cardiology, physical activity, and preventive medicine.[1]

Abstract

Fonseca’s research addresses the physiological and behavioral determinants of cardiovascular health, with particular emphasis on exercise responses, athlete health, and lifestyle-related risk factors. Her work integrates observational and applied methodologies to evaluate how physical activity, motivation, sleep, and substance use influence cardiovascular outcomes and performance indicators.[2]

Keywords

Cardiology; exercise physiology; cardiovascular medicine; athlete health; physical activity; preventive health; sleep quality; sports science.

Introduction

Contemporary cardiovascular research increasingly recognizes the importance of behavioral and environmental determinants of health. Fonseca’s investigations contribute to this perspective by examining how exercise intensity, perceived exertion, nutrition, and psychosocial variables affect cardiovascular adaptation and well-being across athletic and general populations.[3]

Research Profile

According to indexed author records, Fonseca has authored or co-authored 23 Scopus-indexed documents with 85 citations and an h-index of 5. Her scholarship spans cardiology, sports medicine, public health, and kinesiology, reflecting a multidisciplinary approach to cardiovascular prevention and health promotion.[1]

Research Contributions

  • Assessment of cardiovascular responses to exercise under varying behavioral conditions, including alcohol consumption.
  • Investigation of sleep quality, motivation, and mental health among Paralympic athletes.
  • Evaluation of caffeine-related effects on glycaemia and blood pressure in combat sports participants.
  • Analysis of physical activity patterns and self-rated health during the COVID-19 pandemic.

Publications

Selected publications include studies in Nutrients, Sports, Turkish Journal of Kinesiology, and O Mundo da Saúde. Notable recent works examine cardiovascular responses to exercise and alcohol interaction and predictive factors associated with athlete mental health during social isolation.[4]

Research Impact

The practical implications of Fonseca’s work extend to exercise prescription, athlete monitoring, and preventive cardiovascular care. By integrating physiological measures with behavioral indicators, her studies support more comprehensive approaches to health promotion and performance optimization.[5]

Award Suitability

Fonseca’s multidisciplinary output aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. Her emphasis on translational research, preventive health strategies, and evidence-informed interventions demonstrates relevance to current priorities in cardiovascular science and population health.[6]

Conclusion

Sandra Celina Fernandes Fonseca has established a coherent research agenda centered on exercise-related cardiovascular outcomes and health behavior. Her scholarly contributions provide meaningful insights for clinicians, researchers, and public health practitioners seeking to improve cardiovascular well-being through lifestyle-based interventions.

References

  1. Elsevier. (n.d.). Scopus author details: Sandra Celina Fernandes Fonseca, Author ID 57191525441. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57191525441
  2. Fonseca, S. C. F., et al. (2026). Cardiovascular Response to Exercise with and Without Alcohol Consumption. Nutrients.
    DOI: https://doi.org/10.3390/nu18091407
  3. Fonseca, S. C. F., et al. (2026). Predictive Factors of Mental Health in Athletes from the Paralympic Preparation Program During Social Isolation. Sports.
    DOI: https://doi.org/10.3390/sports14040160
  4. Fonseca, S. C. F., et al. (2025). Effects of caffeine on glycaemia and blood pressure in women practising Muay Thai. Turkish Journal of Kinesiology.
    DOI: https://doi.org/10.31459/turkjkin.1704368
  5. Fonseca, S. C. F., et al. (2025). Physical activity practice and negative self-rated health among university students during COVID-19. O Mundo da Saúde.
    DOI: https://doi.org/10.15343/0104-7809.202549e17082025I
  6. Pencis. (n.d.). International Research Awards on Cardiology & Cardiovascular Medicine.
    cardiology-conferences.pencis.com

Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Istanbul University-Cerrahpasa Cardiology Institute | Turkey

Umit Yaşar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.

Profile: Scopus | Orcid

Featured Publications

Yaylalı, Y. T., Yağmur, B., Sinan, Ü. Y., Meriç, M., Başarıcı, İ., Kılıçkıran Avcı, B., Şenol, H., Nalbantgil, S., Küçükoğlu, S., & Öngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.

Kocabaş, U., Ergin, İ., Kıvrak, T., Yılmaz Öztekin, G. M., Tanık, V. O., Özdemir, İ., Avcı Demir, F., Doğduş, M., Şen, T., Altınsoy, M., Üstündağ, S., Urgun, Ö. D., Sinan, Ü. Y., Uygur, B., Yeni, M., & Özçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.

Akyıldız Akçay, F., Sinan, Ü. Y., Gürbüz, D. Ç., Şafak, Ö., Kaya, H., Yüksek, Ü., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.

Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.

Şabanoğlu, C., Sinan, Ü. Y., Akboğa, M. K., Çoner, A., Gök, G., Kocabaş, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Çakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Irene Aracil | Congenital Heart Defects | Young Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Irene Aracil | Congenital Heart Defects | Young Researcher Award

Hospital Fundación Alcorcón | Spain

Ms. Irene Aracil is a medical specialist in Obstetrics and Gynecology at Hospital Universitario Fundación Alcorcón, recognized for her expertise in maternal and fetal medicine. She completed advanced training in obstetrics, gynecology, and human reproduction at leading Spanish institutions and is pursuing a doctoral degree focused on severe preeclampsia and its long-term cardiovascular effects on women’s health. Her research aims to improve maternal and perinatal outcomes through evidence-based and collaborative approaches. Ms. Aracil Moreno has authored 34 indexed publications and several book chapters, with an h index of 5 and a growing number of citations. Her main areas of study include high risk pregnancies, hypertensive disorders of pregnancy, fertility, and gynecological oncology. She has led and contributed to case control and cohort studies on preeclampsia, maternal outcomes in women with heart disease, and acute kidney injury in pregnancy, as well as meta analyses on triplet pregnancies and uterine sarcomas. Through her multidisciplinary collaborations, she bridges obstetrics and cardiovascular research, providing insights into how pregnancy complications affect long-term health. Her scientific work and clinical dedication continue to advance women’s health, making her a leading young researcher in the field of obstetrics and gynecology.

Profiles: Scopus | Orcid

Featured Publications

Aracil Moreno, I., Prieto-Arévalo, R., Ortega-Abad, V., Martín-Manzano, V., Pérez-Burrel, L., Fraile-López, A., Devesa-Cordero, C., Yllana-Pérez, F., Ortega, M. A., & De León-Luis, J. A. (2024). Maternal and perinatal outcomes in pregnant women with heart disease: A case-control study. Journal of Clinical Medicine, 13(17), 5084.

Aracil Moreno, I., Rodríguez-Benitez, P., Ruiz-Minaya, M., Bernal Claverol, M., Ortega Abad, V., Hernández Martin, C., Pintado Recarte, P., Yllana, F., Oliver-Barrecheguren, C., Alvarez-Mon, M., Ortega, M. A., & De Leon-Luis, J. A. (2024). Perinatal characteristics in patients with severe preeclampsia: A case-control nested cohort study. International Journal of Environmental Research and Public Health.

Aracil Moreno, I., Caballero Martín, S., Ceballos Medina, A., Díaz-Crespo, F. J., Navarro, [initial missing], Ortega Abad, V., León-Luis, J. A., & Mata, F. (2021). Perinatal findings and outcomes in a very rare congenital bulky retroperitoneal Ewing sarcoma: A case report. Pediatric Hematology Oncology Journal.

Rodríguez-Benitez, P., Aracil Moreno, I., Oliver Barrecheguren, C., Cuñarro López, Y., Yllana, F., Pintado Recarte, P., et al. (2021). Maternal-perinatal variables in patients with severe preeclampsia who develop acute kidney injury. Journal of Clinical Medicine, 10(23), 5629.

Ruiz-Minaya, M., Mendizabal-Vicente, E., Vasquez-Jimenez, W., Perez-Burrel, L., Aracil-Moreno, I., Agra-Pujol, C., Bernal-Claverol, M., Martínez-Bernal, B. L., Muñoz-Fernández, M., Morote-Gonzalez, M., Ortega, M. A., Lizarraga-Bonelli, S., & De Leon-Luis, J. A. (2022). Retrospective analysis of patients with gynaecological uterine sarcomas in a tertiary centre. Journal of Personalized Medicine, 12(2), 222.

Yiqun Shi | Cardiology | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yiqun Shi | Cardiology | Best Researcher Award

Beijing Friendship Hospital | Capital Medical University | China

Author Profile

Orcid

Early Academic Pursuits

Dr. Yiqun Shi began his academic journey at the Health Science Center of Peking University, where he pursued Clinical Medicine. His early training laid a strong foundation in medical sciences, combining theoretical knowledge with practical exposure. He showcased exceptional dedication and consistently demonstrated a broad vision that extended beyond traditional clinical practices. This formative stage not only strengthened his medical competence but also nurtured his curiosity toward innovative approaches in cardiovascular research.

Professional Endeavors

Building upon his undergraduate foundation, Dr. Shi advanced his medical career at Peking University People’s Hospital, where he successfully completed his doctoral training in Clinical Medicine. His professional path was marked by perseverance, rigorous research, and continuous skill development. He actively engaged in clinical cardiology and emergency medicine, balancing practical medical responsibilities with research pursuits. His dedication to bridging patient care with scientific inquiry has been a defining characteristic of his career trajectory.

Contributions And Research Focus

Dr. Shi’s research primarily focuses on myocardial bridging, a specialized area within cardiovascular medicine. His investigations explore the structural and functional impact of myocardial bridging on coronary anatomy and hemodynamics. Alongside this, he developed expertise in non-invasive hemodynamic assessment methods, aligning his work with contemporary technological advancements in cardiovascular diagnostics. Additionally, his independent study of artificial intelligence and its application to clinical research allowed him to contribute to the development of innovative deep learning models for cardiovascular assessment.

Impact And Influence

The significance of Dr. Shi’s research lies in its ability to inform and refine clinical practices in cardiology. By enhancing the understanding of coronary myocardial bridging, his contributions provide valuable insights into diagnostic approaches and patient management strategies. His work bridges clinical application with technology-driven solutions, thereby influencing not only cardiologists but also the wider medical research community. His ability to merge traditional clinical expertise with modern technological tools places him at the forefront of emerging trends in cardiovascular medicine.

Academic Cites

Dr. Shi has published widely in peer-reviewed international journals, with his work receiving citations from academic peers and fellow researchers in cardiology and emergency medicine. His publications highlight both clinical case insights and advanced methodological research, reflecting the interdisciplinary nature of his academic endeavors. The growing recognition of his work demonstrates his increasing influence in shaping discussions around myocardial bridging and cardiovascular diagnostics.

Legacy And Future Contributions

Looking ahead, Dr. Shi is committed to advancing innovative, patient-centered approaches in cardiology. His legacy lies in combining clinical medicine with cutting-edge technologies such as artificial intelligence and non-invasive assessment techniques. By continuing to investigate myocardial bridging and related cardiovascular conditions, he aims to create pathways that integrate early detection, precision diagnostics, and improved patient outcomes. His contributions are likely to inspire future researchers, strengthening the bridge between traditional medicine and evolving scientific innovations.

Conclusion

Dr. Yiqun Shi represents the embodiment of academic excellence, professional dedication, and research-driven innovation in the field of cardiology. His career reflects a consistent effort to integrate clinical practice with technological progress, addressing pressing challenges in cardiovascular medicine. Through his pioneering work on myocardial bridging and his commitment to harnessing artificial intelligence, Dr. Shi stands as a promising contributor to both present and future advancements in global medical research.

Notable Publication

"Impact of Myocardial Bridging on Hemodynamics Evaluated by Coronary Angiography-Derived Fractional Flow Reserve"

Authors: Yiqun Shi, Jian Liu
Journal: The American Journal of Cardiology
Year: 2025

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award 

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

  • Dean of the Experimental Animal Center 🐁
  • Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

  • Cross-organ communication in cardiovascular and metabolic diseases
  • Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
  • Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Christopher Coe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Christopher Coe | Cardiovascular Researches | Best Research Article Award

Prof. Christopher Coe, University of Wisconsin-Madison, United States

Prof. Christopher Coe is a distinguished professor emeritus in psychology at the University of Wisconsin-Madison, recognized for his pioneering work in psychoneuroimmunology and developmental psychobiology. With a career spanning leading institutions, he has made significant contributions to understanding the interaction of stress, immune function, and social behavior, earning numerous accolades for his research and teaching.

Author Profile:

Scopus Profile

Orcid Profile

Educational Details:

Prof. Christopher Coe, Professor Emeritus at the University of Wisconsin-Madison, is a distinguished expert in biological psychology and psychoneuroimmunology. He earned a B.A. in Anthropology (cum laude) with a minor in Biology from City College, City University of New York, in 1971, and a Ph.D. in Biological Psychology from Downstate Medical Center, SUNY, in 1976. Following this, he completed a postdoctoral fellowship in developmental psychobiology at Stanford University Medical School (1976-77). Prof. Coe’s career has been marked by groundbreaking research on the interplay between behavior, stress, and immune function, as well as exceptional contributions to teaching and academic leadership.

Professional Experience:

Prof. Christopher Coe has had an illustrious academic career spanning over five decades, beginning as a Lecturer at the American Museum of Natural History in New York (1970-71). He held key roles at Stanford University, including Postdoctoral Fellow (1976-77), Assistant Director of the Outdoor Primate Facility (1977-79), and Assistant Professor at the School of Medicine (1981-85). Joining the University of Wisconsin-Madison in 1985, he served as Associate Professor, Director of the Harlow Center for Biological Psychology, and later as Professor (1988-2022). Honored as the W.B. Cannon Professor of Biopsychology (2001-2022), he is now Professor Emeritus and Honorary Scholar.

Research Interests:

Prof. Christopher Coe’s research spans developmental psychobiology, psychoneuroimmunology, and sociophysiology. He investigates how early life experiences shape biological and psychological development, the interplay between stress, behavior, and immune system function, and the biological basis of social interactions and their effects on health and well-being.

Research Skills:

Prof. Christopher Coe specializes in designing and conducting longitudinal studies in developmental psychobiology, with expertise in psychoneuroimmunology and animal behavioral research. He is also proficient in sociophysiological measurement techniques and advanced data analysis, enabling a comprehensive understanding of the biological and behavioral dynamics underlying health and development.

Research Projects:

Prof. Christopher Coe has spearheaded pioneering research projects on the impact of stress and early life experiences on immune development, behavioral and physiological adaptations in primates, and the psychosocial factors influencing health and resilience throughout the lifespan.

Awards and Honors:

Prof. Christopher Coe has received numerous prestigious awards, including the Chancellor’s Award for Excellence in Teaching (1997), the WARF Professorship as W.B. Cannon Professor (2001), and the Norman Cousins Award for Psychoneuroimmunology Research (2001). Other honors include the Ziskind-Somerfield Award for Innovative Research (2004), the Hilldale Award for Teaching and Scholarship (2006), the P. Barchas Award for Sociophysiology Research (2008), and an Honorary Professorship from South China Normal University (2009). He also earned the Best Research in Health and Society accolade (2011) and the UW Board of Regents Teaching Excellence Award (2013).

Conclusion:

Prof. Christopher Coe’s career exemplifies excellence in academic leadership, innovative research, and impactful teaching. His contributions to psychology and biopsychology continue to inspire scholars and shape the understanding of health, behavior, and development.

Top Notable Publications:

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease

Authors: Hansen, J.L., Rumble, M.E., Coe, C.L., Hematti, P., Costanzo, E.S.

Year: 2025

Citations: 0

Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation

Authors: Bu, Y., Burks, J., Yang, K., Coleman, T.P., Lerman, I.

Year: 2024

Citations: 0

Higher inflammatory proteins predict future depressive symptom severity among adolescents with lower emotional clarity

Authors: Stephenson, A.R., Ka-Yi Chat, I., Bisgay, A.T., Abramson, L.Y., Alloy, L.B.

Year: 2024

Citations: 0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Authors: Turner, D.G.P., De Lange, W.J., Zhu, Y., Ralphe, J.C., Glukhov, A.V.

Year: 2024

Citations: 2

Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys

Authors: Coe, C.L., Nimityongskul, F., Lubach, G.R., Rancour, D., Schomburg, F.M.

Year: 2024

Citations: 0

Exercise does not cause post-exertional malaise in Veterans with Gulf War Illness: A randomized, controlled, dose–response, crossover study

Authors: Boruch, A.E., Barhorst, E.E., Rayne, T.J., Cook, D.B., Lindheimer, J.B.

Year: 2024

Citations: 1

Financial Hardship and Age-Related Decrements in Kidney Function among Black and White Adults in the Midlife in the United States Study

Authors: Surachman, A., Harhay, M., Santos, A.R., Almeida, D.M., Coe, C.L.

Year: 2024

Citations: 1

Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents

Authors: Wood, E.K., Reid, B.M., Sheerar, D.S., Gunnar, M.R., Coe, C.L.

Year: 2024

Citations: 1

Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency Induced Metabolic Brain Dysfunction in Infant Rhesus Monkeys

Authors: Sandri, B.J., Kim, J., Lubach, G.R., Coe, C.L., Rao, R.B.

Year: 2024

Citations: 3

The Impact of Early and Recent Life Stress on Trajectories of Inflammatory Biomarkers in a Diverse Sample of Adolescents

Authors: Kautz, M.M., McArthur, B.A., Moriarity, D.P., Abramson, L.Y., Alloy, L.B.

Year: 2023

Citations: 4